Overview
Jung-chi Liao practices practicing medicine in Nankang, Taiwan.
Liao is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Spinocerebellar Ataxia Type 11, Primary Ciliary Dyskinesia (PCD), and Xeroderma Pigmentosum.
They are actively involved in clinical research, co-authoring 25 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jung-chi Liao
Is Jung-chi Liao a top-rated expert for Spinocerebellar Ataxia Type 11?
MediFind is an objective health platform that identifies experts based on real-world data. Jung-chi Liao is classified as an Advanced expert for Spinocerebellar Ataxia Type 11, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jung-chi Liao participate in research or clinical trials?
Yes. Jung-chi Liao has published 25 articles and abstracts on conditions like Spinocerebellar Ataxia Type 11. You can view a list of Jung-chi Liao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Spinocerebellar Ataxia Type 11
- Experienced
- Primary Ciliary Dyskinesia (PCD)
- Xeroderma PigmentosumLiao isExperienced. Learn about Xeroderma Pigmentosum.